New Package Leaflets Needed For EU Drugs With Ethanol Excipient
Changes Needed To Explain Potential Effects In Children
New EU guidance has been issued to help sponsors update the package leaflets of medicines that contain ethanol as an excipient to better convey warnings of potential effects in children.
You may also be interested in...
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.